v3.19.3
Note 3 - Reverse Merger (Details Textual)
1 Months Ended 3 Months Ended 9 Months Ended
May 29, 2019
USD ($)
$ / shares
May 03, 2019
USD ($)
shares
Oct. 11, 2018
May 31, 2019
shares
Sep. 30, 2019
USD ($)
Sep. 30, 2019
USD ($)
Stockholders' Equity Note, Stock Split, Conversion Ratio     0.0359      
Debt Conversion, Converted Instrument, Shares Issued | shares       367,041    
Number of Shares Held by Equity Holders | shares   4,936,784        
Debt Instrument, Convertible, Beneficial Conversion Feature         $ 2,100,000  
Interest Expense [Member]            
Debt Instrument, Convertible, Beneficial Conversion Feature           $ 2,100,000
Alliqua Biomedical, Inc. [Member]            
Business Acquisition, Exchange Ratio   0.0359        
Dividends, Total $ 5,245,000          
Common Stock, Dividends, Per Share, Cash Paid | $ / shares $ 1.05          
Reverse Stock Split From [Member] | Alliqua Biomedical, Inc. [Member]            
Stockholders' Equity Note, Stock Split, Conversion Ratio   6        
Alliqua Biomedical, Inc. [Member]            
Merger Agreement, Percentage Ownership in Combined Company, Acquirer   86.00%        
Merger Agreement, Percentage Ownership in Combined Company, Acquiree   14.00%        
Alliqua Biomedical, Inc. [Member] | Conversion of Notes into Series B Convertible Preferred Stock [Member]            
Debt Conversion, Original Debt, Amount, Principal   $ 3,000,000        
Debt Conversion, Original Debt, Amount, Cumulative Accrued Interest   $ 203,000        
Debt Conversion, Converted Instrument, Shares Issued | shares   367,041